Medical Care
Global Drug Particle Engineering Service Market Research Report 2025
- Mar 11, 25
- ID: 12752
- Pages: 87
- Figures: 82
- Views: 27
The global market for Drug Particle Engineering Service was valued at US$ 1180 million in the year 2024 and is projected to reach a revised size of US$ 1578 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Drug particle engineering service is a comprehensive service that provides particle design, preparation, characterization, and optimization services for drug development and production. This service aims to improve the physical properties of drugs, increase their solubility and bioavailability, and thereby enhance their efficacy and safety through advanced particle engineering techniques. Drug Particle Engineering Service covers the entire process from the design and preparation of drug particles to their characterization and optimization, including the regulation of particle size, shape, and surface properties. Through this service, customers can obtain drug products with specific particle characteristics to meet their needs for new drug development and production. Additionally, this service provides professional technical support and solutions to help customers solve particle-related issues encountered during drug development and production.
North American market for Drug Particle Engineering Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Drug Particle Engineering Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Drug Particle Engineering Service in Oral Medications is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Drug Particle Engineering Service include Lonza, CritiTech, EUROAPI, Schedio, Solid State Pharma, Hovione, Evonik, Balchem, AP-Process, Micromeritics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Drug Particle Engineering Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Particle Engineering Service.
The Drug Particle Engineering Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Particle Engineering Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Particle Engineering Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
CritiTech
EUROAPI
Schedio
Solid State Pharma
Hovione
Evonik
Balchem
AP-Process
Micromeritics
Wuxi AppTec
Xedev
Munit
Segment by Type
Standard Drug Particle Engineering Service
Customized Drug Particle Engineering Service
Segment by Application
Oral Medications
Parenteral Medications
Inhaled Medications
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Particle Engineering Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Drug particle engineering service is a comprehensive service that provides particle design, preparation, characterization, and optimization services for drug development and production. This service aims to improve the physical properties of drugs, increase their solubility and bioavailability, and thereby enhance their efficacy and safety through advanced particle engineering techniques. Drug Particle Engineering Service covers the entire process from the design and preparation of drug particles to their characterization and optimization, including the regulation of particle size, shape, and surface properties. Through this service, customers can obtain drug products with specific particle characteristics to meet their needs for new drug development and production. Additionally, this service provides professional technical support and solutions to help customers solve particle-related issues encountered during drug development and production.
North American market for Drug Particle Engineering Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Drug Particle Engineering Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Drug Particle Engineering Service in Oral Medications is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Drug Particle Engineering Service include Lonza, CritiTech, EUROAPI, Schedio, Solid State Pharma, Hovione, Evonik, Balchem, AP-Process, Micromeritics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Drug Particle Engineering Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Particle Engineering Service.
The Drug Particle Engineering Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Particle Engineering Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Particle Engineering Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
CritiTech
EUROAPI
Schedio
Solid State Pharma
Hovione
Evonik
Balchem
AP-Process
Micromeritics
Wuxi AppTec
Xedev
Munit
Segment by Type
Standard Drug Particle Engineering Service
Customized Drug Particle Engineering Service
Segment by Application
Oral Medications
Parenteral Medications
Inhaled Medications
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Particle Engineering Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Particle Engineering Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Standard Drug Particle Engineering Service
1.2.3 Customized Drug Particle Engineering Service
1.3 Market by Application
1.3.1 Global Drug Particle Engineering Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oral Medications
1.3.3 Parenteral Medications
1.3.4 Inhaled Medications
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Particle Engineering Service Market Perspective (2020-2031)
2.2 Global Drug Particle Engineering Service Growth Trends by Region
2.2.1 Global Drug Particle Engineering Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Particle Engineering Service Historic Market Size by Region (2020-2025)
2.2.3 Drug Particle Engineering Service Forecasted Market Size by Region (2026-2031)
2.3 Drug Particle Engineering Service Market Dynamics
2.3.1 Drug Particle Engineering Service Industry Trends
2.3.2 Drug Particle Engineering Service Market Drivers
2.3.3 Drug Particle Engineering Service Market Challenges
2.3.4 Drug Particle Engineering Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Particle Engineering Service Players by Revenue
3.1.1 Global Top Drug Particle Engineering Service Players by Revenue (2020-2025)
3.1.2 Global Drug Particle Engineering Service Revenue Market Share by Players (2020-2025)
3.2 Global Drug Particle Engineering Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Particle Engineering Service Revenue
3.4 Global Drug Particle Engineering Service Market Concentration Ratio
3.4.1 Global Drug Particle Engineering Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Particle Engineering Service Revenue in 2024
3.5 Global Key Players of Drug Particle Engineering Service Head office and Area Served
3.6 Global Key Players of Drug Particle Engineering Service, Product and Application
3.7 Global Key Players of Drug Particle Engineering Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Particle Engineering Service Breakdown Data by Type
4.1 Global Drug Particle Engineering Service Historic Market Size by Type (2020-2025)
4.2 Global Drug Particle Engineering Service Forecasted Market Size by Type (2026-2031)
5 Drug Particle Engineering Service Breakdown Data by Application
5.1 Global Drug Particle Engineering Service Historic Market Size by Application (2020-2025)
5.2 Global Drug Particle Engineering Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Particle Engineering Service Market Size (2020-2031)
6.2 North America Drug Particle Engineering Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Particle Engineering Service Market Size by Country (2020-2025)
6.4 North America Drug Particle Engineering Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Particle Engineering Service Market Size (2020-2031)
7.2 Europe Drug Particle Engineering Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Particle Engineering Service Market Size by Country (2020-2025)
7.4 Europe Drug Particle Engineering Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Particle Engineering Service Market Size (2020-2031)
8.2 Asia-Pacific Drug Particle Engineering Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Particle Engineering Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Particle Engineering Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Particle Engineering Service Market Size (2020-2031)
9.2 Latin America Drug Particle Engineering Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Particle Engineering Service Market Size by Country (2020-2025)
9.4 Latin America Drug Particle Engineering Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Particle Engineering Service Market Size (2020-2031)
10.2 Middle East & Africa Drug Particle Engineering Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Particle Engineering Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Particle Engineering Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Drug Particle Engineering Service Introduction
11.1.4 Lonza Revenue in Drug Particle Engineering Service Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 CritiTech
11.2.1 CritiTech Company Details
11.2.2 CritiTech Business Overview
11.2.3 CritiTech Drug Particle Engineering Service Introduction
11.2.4 CritiTech Revenue in Drug Particle Engineering Service Business (2020-2025)
11.2.5 CritiTech Recent Development
11.3 EUROAPI
11.3.1 EUROAPI Company Details
11.3.2 EUROAPI Business Overview
11.3.3 EUROAPI Drug Particle Engineering Service Introduction
11.3.4 EUROAPI Revenue in Drug Particle Engineering Service Business (2020-2025)
11.3.5 EUROAPI Recent Development
11.4 Schedio
11.4.1 Schedio Company Details
11.4.2 Schedio Business Overview
11.4.3 Schedio Drug Particle Engineering Service Introduction
11.4.4 Schedio Revenue in Drug Particle Engineering Service Business (2020-2025)
11.4.5 Schedio Recent Development
11.5 Solid State Pharma
11.5.1 Solid State Pharma Company Details
11.5.2 Solid State Pharma Business Overview
11.5.3 Solid State Pharma Drug Particle Engineering Service Introduction
11.5.4 Solid State Pharma Revenue in Drug Particle Engineering Service Business (2020-2025)
11.5.5 Solid State Pharma Recent Development
11.6 Hovione
11.6.1 Hovione Company Details
11.6.2 Hovione Business Overview
11.6.3 Hovione Drug Particle Engineering Service Introduction
11.6.4 Hovione Revenue in Drug Particle Engineering Service Business (2020-2025)
11.6.5 Hovione Recent Development
11.7 Evonik
11.7.1 Evonik Company Details
11.7.2 Evonik Business Overview
11.7.3 Evonik Drug Particle Engineering Service Introduction
11.7.4 Evonik Revenue in Drug Particle Engineering Service Business (2020-2025)
11.7.5 Evonik Recent Development
11.8 Balchem
11.8.1 Balchem Company Details
11.8.2 Balchem Business Overview
11.8.3 Balchem Drug Particle Engineering Service Introduction
11.8.4 Balchem Revenue in Drug Particle Engineering Service Business (2020-2025)
11.8.5 Balchem Recent Development
11.9 AP-Process
11.9.1 AP-Process Company Details
11.9.2 AP-Process Business Overview
11.9.3 AP-Process Drug Particle Engineering Service Introduction
11.9.4 AP-Process Revenue in Drug Particle Engineering Service Business (2020-2025)
11.9.5 AP-Process Recent Development
11.10 Micromeritics
11.10.1 Micromeritics Company Details
11.10.2 Micromeritics Business Overview
11.10.3 Micromeritics Drug Particle Engineering Service Introduction
11.10.4 Micromeritics Revenue in Drug Particle Engineering Service Business (2020-2025)
11.10.5 Micromeritics Recent Development
11.11 Wuxi AppTec
11.11.1 Wuxi AppTec Company Details
11.11.2 Wuxi AppTec Business Overview
11.11.3 Wuxi AppTec Drug Particle Engineering Service Introduction
11.11.4 Wuxi AppTec Revenue in Drug Particle Engineering Service Business (2020-2025)
11.11.5 Wuxi AppTec Recent Development
11.12 Xedev
11.12.1 Xedev Company Details
11.12.2 Xedev Business Overview
11.12.3 Xedev Drug Particle Engineering Service Introduction
11.12.4 Xedev Revenue in Drug Particle Engineering Service Business (2020-2025)
11.12.5 Xedev Recent Development
11.13 Munit
11.13.1 Munit Company Details
11.13.2 Munit Business Overview
11.13.3 Munit Drug Particle Engineering Service Introduction
11.13.4 Munit Revenue in Drug Particle Engineering Service Business (2020-2025)
11.13.5 Munit Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Particle Engineering Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Standard Drug Particle Engineering Service
1.2.3 Customized Drug Particle Engineering Service
1.3 Market by Application
1.3.1 Global Drug Particle Engineering Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oral Medications
1.3.3 Parenteral Medications
1.3.4 Inhaled Medications
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Particle Engineering Service Market Perspective (2020-2031)
2.2 Global Drug Particle Engineering Service Growth Trends by Region
2.2.1 Global Drug Particle Engineering Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Particle Engineering Service Historic Market Size by Region (2020-2025)
2.2.3 Drug Particle Engineering Service Forecasted Market Size by Region (2026-2031)
2.3 Drug Particle Engineering Service Market Dynamics
2.3.1 Drug Particle Engineering Service Industry Trends
2.3.2 Drug Particle Engineering Service Market Drivers
2.3.3 Drug Particle Engineering Service Market Challenges
2.3.4 Drug Particle Engineering Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Particle Engineering Service Players by Revenue
3.1.1 Global Top Drug Particle Engineering Service Players by Revenue (2020-2025)
3.1.2 Global Drug Particle Engineering Service Revenue Market Share by Players (2020-2025)
3.2 Global Drug Particle Engineering Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Particle Engineering Service Revenue
3.4 Global Drug Particle Engineering Service Market Concentration Ratio
3.4.1 Global Drug Particle Engineering Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Particle Engineering Service Revenue in 2024
3.5 Global Key Players of Drug Particle Engineering Service Head office and Area Served
3.6 Global Key Players of Drug Particle Engineering Service, Product and Application
3.7 Global Key Players of Drug Particle Engineering Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Particle Engineering Service Breakdown Data by Type
4.1 Global Drug Particle Engineering Service Historic Market Size by Type (2020-2025)
4.2 Global Drug Particle Engineering Service Forecasted Market Size by Type (2026-2031)
5 Drug Particle Engineering Service Breakdown Data by Application
5.1 Global Drug Particle Engineering Service Historic Market Size by Application (2020-2025)
5.2 Global Drug Particle Engineering Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Particle Engineering Service Market Size (2020-2031)
6.2 North America Drug Particle Engineering Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Particle Engineering Service Market Size by Country (2020-2025)
6.4 North America Drug Particle Engineering Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Particle Engineering Service Market Size (2020-2031)
7.2 Europe Drug Particle Engineering Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Particle Engineering Service Market Size by Country (2020-2025)
7.4 Europe Drug Particle Engineering Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Particle Engineering Service Market Size (2020-2031)
8.2 Asia-Pacific Drug Particle Engineering Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Particle Engineering Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Particle Engineering Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Particle Engineering Service Market Size (2020-2031)
9.2 Latin America Drug Particle Engineering Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Particle Engineering Service Market Size by Country (2020-2025)
9.4 Latin America Drug Particle Engineering Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Particle Engineering Service Market Size (2020-2031)
10.2 Middle East & Africa Drug Particle Engineering Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Particle Engineering Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Particle Engineering Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Drug Particle Engineering Service Introduction
11.1.4 Lonza Revenue in Drug Particle Engineering Service Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 CritiTech
11.2.1 CritiTech Company Details
11.2.2 CritiTech Business Overview
11.2.3 CritiTech Drug Particle Engineering Service Introduction
11.2.4 CritiTech Revenue in Drug Particle Engineering Service Business (2020-2025)
11.2.5 CritiTech Recent Development
11.3 EUROAPI
11.3.1 EUROAPI Company Details
11.3.2 EUROAPI Business Overview
11.3.3 EUROAPI Drug Particle Engineering Service Introduction
11.3.4 EUROAPI Revenue in Drug Particle Engineering Service Business (2020-2025)
11.3.5 EUROAPI Recent Development
11.4 Schedio
11.4.1 Schedio Company Details
11.4.2 Schedio Business Overview
11.4.3 Schedio Drug Particle Engineering Service Introduction
11.4.4 Schedio Revenue in Drug Particle Engineering Service Business (2020-2025)
11.4.5 Schedio Recent Development
11.5 Solid State Pharma
11.5.1 Solid State Pharma Company Details
11.5.2 Solid State Pharma Business Overview
11.5.3 Solid State Pharma Drug Particle Engineering Service Introduction
11.5.4 Solid State Pharma Revenue in Drug Particle Engineering Service Business (2020-2025)
11.5.5 Solid State Pharma Recent Development
11.6 Hovione
11.6.1 Hovione Company Details
11.6.2 Hovione Business Overview
11.6.3 Hovione Drug Particle Engineering Service Introduction
11.6.4 Hovione Revenue in Drug Particle Engineering Service Business (2020-2025)
11.6.5 Hovione Recent Development
11.7 Evonik
11.7.1 Evonik Company Details
11.7.2 Evonik Business Overview
11.7.3 Evonik Drug Particle Engineering Service Introduction
11.7.4 Evonik Revenue in Drug Particle Engineering Service Business (2020-2025)
11.7.5 Evonik Recent Development
11.8 Balchem
11.8.1 Balchem Company Details
11.8.2 Balchem Business Overview
11.8.3 Balchem Drug Particle Engineering Service Introduction
11.8.4 Balchem Revenue in Drug Particle Engineering Service Business (2020-2025)
11.8.5 Balchem Recent Development
11.9 AP-Process
11.9.1 AP-Process Company Details
11.9.2 AP-Process Business Overview
11.9.3 AP-Process Drug Particle Engineering Service Introduction
11.9.4 AP-Process Revenue in Drug Particle Engineering Service Business (2020-2025)
11.9.5 AP-Process Recent Development
11.10 Micromeritics
11.10.1 Micromeritics Company Details
11.10.2 Micromeritics Business Overview
11.10.3 Micromeritics Drug Particle Engineering Service Introduction
11.10.4 Micromeritics Revenue in Drug Particle Engineering Service Business (2020-2025)
11.10.5 Micromeritics Recent Development
11.11 Wuxi AppTec
11.11.1 Wuxi AppTec Company Details
11.11.2 Wuxi AppTec Business Overview
11.11.3 Wuxi AppTec Drug Particle Engineering Service Introduction
11.11.4 Wuxi AppTec Revenue in Drug Particle Engineering Service Business (2020-2025)
11.11.5 Wuxi AppTec Recent Development
11.12 Xedev
11.12.1 Xedev Company Details
11.12.2 Xedev Business Overview
11.12.3 Xedev Drug Particle Engineering Service Introduction
11.12.4 Xedev Revenue in Drug Particle Engineering Service Business (2020-2025)
11.12.5 Xedev Recent Development
11.13 Munit
11.13.1 Munit Company Details
11.13.2 Munit Business Overview
11.13.3 Munit Drug Particle Engineering Service Introduction
11.13.4 Munit Revenue in Drug Particle Engineering Service Business (2020-2025)
11.13.5 Munit Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Drug Particle Engineering Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Standard Drug Particle Engineering Service
Table 3. Key Players of Customized Drug Particle Engineering Service
Table 4. Global Drug Particle Engineering Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Drug Particle Engineering Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Drug Particle Engineering Service Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Drug Particle Engineering Service Market Share by Region (2020-2025)
Table 8. Global Drug Particle Engineering Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Drug Particle Engineering Service Market Share by Region (2026-2031)
Table 10. Drug Particle Engineering Service Market Trends
Table 11. Drug Particle Engineering Service Market Drivers
Table 12. Drug Particle Engineering Service Market Challenges
Table 13. Drug Particle Engineering Service Market Restraints
Table 14. Global Drug Particle Engineering Service Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Drug Particle Engineering Service Market Share by Players (2020-2025)
Table 16. Global Top Drug Particle Engineering Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Particle Engineering Service as of 2024)
Table 17. Ranking of Global Top Drug Particle Engineering Service Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Drug Particle Engineering Service Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Drug Particle Engineering Service, Headquarters and Area Served
Table 20. Global Key Players of Drug Particle Engineering Service, Product and Application
Table 21. Global Key Players of Drug Particle Engineering Service, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Particle Engineering Service Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Drug Particle Engineering Service Revenue Market Share by Type (2020-2025)
Table 25. Global Drug Particle Engineering Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Drug Particle Engineering Service Revenue Market Share by Type (2026-2031)
Table 27. Global Drug Particle Engineering Service Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Drug Particle Engineering Service Revenue Market Share by Application (2020-2025)
Table 29. Global Drug Particle Engineering Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Drug Particle Engineering Service Revenue Market Share by Application (2026-2031)
Table 31. North America Drug Particle Engineering Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Drug Particle Engineering Service Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Drug Particle Engineering Service Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Drug Particle Engineering Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Drug Particle Engineering Service Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Drug Particle Engineering Service Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Drug Particle Engineering Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Drug Particle Engineering Service Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Drug Particle Engineering Service Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Drug Particle Engineering Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Drug Particle Engineering Service Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Drug Particle Engineering Service Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Drug Particle Engineering Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Drug Particle Engineering Service Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Drug Particle Engineering Service Market Size by Country (2026-2031) & (US$ Million)
Table 46. Lonza Company Details
Table 47. Lonza Business Overview
Table 48. Lonza Drug Particle Engineering Service Product
Table 49. Lonza Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 50. Lonza Recent Development
Table 51. CritiTech Company Details
Table 52. CritiTech Business Overview
Table 53. CritiTech Drug Particle Engineering Service Product
Table 54. CritiTech Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 55. CritiTech Recent Development
Table 56. EUROAPI Company Details
Table 57. EUROAPI Business Overview
Table 58. EUROAPI Drug Particle Engineering Service Product
Table 59. EUROAPI Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 60. EUROAPI Recent Development
Table 61. Schedio Company Details
Table 62. Schedio Business Overview
Table 63. Schedio Drug Particle Engineering Service Product
Table 64. Schedio Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 65. Schedio Recent Development
Table 66. Solid State Pharma Company Details
Table 67. Solid State Pharma Business Overview
Table 68. Solid State Pharma Drug Particle Engineering Service Product
Table 69. Solid State Pharma Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 70. Solid State Pharma Recent Development
Table 71. Hovione Company Details
Table 72. Hovione Business Overview
Table 73. Hovione Drug Particle Engineering Service Product
Table 74. Hovione Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 75. Hovione Recent Development
Table 76. Evonik Company Details
Table 77. Evonik Business Overview
Table 78. Evonik Drug Particle Engineering Service Product
Table 79. Evonik Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 80. Evonik Recent Development
Table 81. Balchem Company Details
Table 82. Balchem Business Overview
Table 83. Balchem Drug Particle Engineering Service Product
Table 84. Balchem Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 85. Balchem Recent Development
Table 86. AP-Process Company Details
Table 87. AP-Process Business Overview
Table 88. AP-Process Drug Particle Engineering Service Product
Table 89. AP-Process Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 90. AP-Process Recent Development
Table 91. Micromeritics Company Details
Table 92. Micromeritics Business Overview
Table 93. Micromeritics Drug Particle Engineering Service Product
Table 94. Micromeritics Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 95. Micromeritics Recent Development
Table 96. Wuxi AppTec Company Details
Table 97. Wuxi AppTec Business Overview
Table 98. Wuxi AppTec Drug Particle Engineering Service Product
Table 99. Wuxi AppTec Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 100. Wuxi AppTec Recent Development
Table 101. Xedev Company Details
Table 102. Xedev Business Overview
Table 103. Xedev Drug Particle Engineering Service Product
Table 104. Xedev Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 105. Xedev Recent Development
Table 106. Munit Company Details
Table 107. Munit Business Overview
Table 108. Munit Drug Particle Engineering Service Product
Table 109. Munit Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 110. Munit Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Drug Particle Engineering Service Picture
Figure 2. Global Drug Particle Engineering Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug Particle Engineering Service Market Share by Type: 2024 VS 2031
Figure 4. Standard Drug Particle Engineering Service Features
Figure 5. Customized Drug Particle Engineering Service Features
Figure 6. Global Drug Particle Engineering Service Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Drug Particle Engineering Service Market Share by Application: 2024 VS 2031
Figure 8. Oral Medications Case Studies
Figure 9. Parenteral Medications Case Studies
Figure 10. Inhaled Medications Case Studies
Figure 11. Others Case Studies
Figure 12. Drug Particle Engineering Service Report Years Considered
Figure 13. Global Drug Particle Engineering Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Drug Particle Engineering Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Drug Particle Engineering Service Market Share by Region: 2024 VS 2031
Figure 16. Global Drug Particle Engineering Service Market Share by Players in 2024
Figure 17. Global Top Drug Particle Engineering Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Particle Engineering Service as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Drug Particle Engineering Service Revenue in 2024
Figure 19. North America Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Drug Particle Engineering Service Market Share by Country (2020-2031)
Figure 21. United States Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Drug Particle Engineering Service Market Share by Country (2020-2031)
Figure 25. Germany Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Drug Particle Engineering Service Market Share by Region (2020-2031)
Figure 33. China Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Drug Particle Engineering Service Market Share by Country (2020-2031)
Figure 41. Mexico Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Drug Particle Engineering Service Market Share by Country (2020-2031)
Figure 45. Turkey Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Lonza Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 49. CritiTech Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 50. EUROAPI Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 51. Schedio Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 52. Solid State Pharma Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 53. Hovione Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 54. Evonik Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 55. Balchem Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 56. AP-Process Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 57. Micromeritics Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 58. Wuxi AppTec Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 59. Xedev Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 60. Munit Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Drug Particle Engineering Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Standard Drug Particle Engineering Service
Table 3. Key Players of Customized Drug Particle Engineering Service
Table 4. Global Drug Particle Engineering Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Drug Particle Engineering Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Drug Particle Engineering Service Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Drug Particle Engineering Service Market Share by Region (2020-2025)
Table 8. Global Drug Particle Engineering Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Drug Particle Engineering Service Market Share by Region (2026-2031)
Table 10. Drug Particle Engineering Service Market Trends
Table 11. Drug Particle Engineering Service Market Drivers
Table 12. Drug Particle Engineering Service Market Challenges
Table 13. Drug Particle Engineering Service Market Restraints
Table 14. Global Drug Particle Engineering Service Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Drug Particle Engineering Service Market Share by Players (2020-2025)
Table 16. Global Top Drug Particle Engineering Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Particle Engineering Service as of 2024)
Table 17. Ranking of Global Top Drug Particle Engineering Service Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Drug Particle Engineering Service Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Drug Particle Engineering Service, Headquarters and Area Served
Table 20. Global Key Players of Drug Particle Engineering Service, Product and Application
Table 21. Global Key Players of Drug Particle Engineering Service, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Particle Engineering Service Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Drug Particle Engineering Service Revenue Market Share by Type (2020-2025)
Table 25. Global Drug Particle Engineering Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Drug Particle Engineering Service Revenue Market Share by Type (2026-2031)
Table 27. Global Drug Particle Engineering Service Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Drug Particle Engineering Service Revenue Market Share by Application (2020-2025)
Table 29. Global Drug Particle Engineering Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Drug Particle Engineering Service Revenue Market Share by Application (2026-2031)
Table 31. North America Drug Particle Engineering Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Drug Particle Engineering Service Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Drug Particle Engineering Service Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Drug Particle Engineering Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Drug Particle Engineering Service Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Drug Particle Engineering Service Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Drug Particle Engineering Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Drug Particle Engineering Service Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Drug Particle Engineering Service Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Drug Particle Engineering Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Drug Particle Engineering Service Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Drug Particle Engineering Service Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Drug Particle Engineering Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Drug Particle Engineering Service Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Drug Particle Engineering Service Market Size by Country (2026-2031) & (US$ Million)
Table 46. Lonza Company Details
Table 47. Lonza Business Overview
Table 48. Lonza Drug Particle Engineering Service Product
Table 49. Lonza Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 50. Lonza Recent Development
Table 51. CritiTech Company Details
Table 52. CritiTech Business Overview
Table 53. CritiTech Drug Particle Engineering Service Product
Table 54. CritiTech Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 55. CritiTech Recent Development
Table 56. EUROAPI Company Details
Table 57. EUROAPI Business Overview
Table 58. EUROAPI Drug Particle Engineering Service Product
Table 59. EUROAPI Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 60. EUROAPI Recent Development
Table 61. Schedio Company Details
Table 62. Schedio Business Overview
Table 63. Schedio Drug Particle Engineering Service Product
Table 64. Schedio Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 65. Schedio Recent Development
Table 66. Solid State Pharma Company Details
Table 67. Solid State Pharma Business Overview
Table 68. Solid State Pharma Drug Particle Engineering Service Product
Table 69. Solid State Pharma Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 70. Solid State Pharma Recent Development
Table 71. Hovione Company Details
Table 72. Hovione Business Overview
Table 73. Hovione Drug Particle Engineering Service Product
Table 74. Hovione Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 75. Hovione Recent Development
Table 76. Evonik Company Details
Table 77. Evonik Business Overview
Table 78. Evonik Drug Particle Engineering Service Product
Table 79. Evonik Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 80. Evonik Recent Development
Table 81. Balchem Company Details
Table 82. Balchem Business Overview
Table 83. Balchem Drug Particle Engineering Service Product
Table 84. Balchem Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 85. Balchem Recent Development
Table 86. AP-Process Company Details
Table 87. AP-Process Business Overview
Table 88. AP-Process Drug Particle Engineering Service Product
Table 89. AP-Process Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 90. AP-Process Recent Development
Table 91. Micromeritics Company Details
Table 92. Micromeritics Business Overview
Table 93. Micromeritics Drug Particle Engineering Service Product
Table 94. Micromeritics Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 95. Micromeritics Recent Development
Table 96. Wuxi AppTec Company Details
Table 97. Wuxi AppTec Business Overview
Table 98. Wuxi AppTec Drug Particle Engineering Service Product
Table 99. Wuxi AppTec Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 100. Wuxi AppTec Recent Development
Table 101. Xedev Company Details
Table 102. Xedev Business Overview
Table 103. Xedev Drug Particle Engineering Service Product
Table 104. Xedev Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 105. Xedev Recent Development
Table 106. Munit Company Details
Table 107. Munit Business Overview
Table 108. Munit Drug Particle Engineering Service Product
Table 109. Munit Revenue in Drug Particle Engineering Service Business (2020-2025) & (US$ Million)
Table 110. Munit Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Drug Particle Engineering Service Picture
Figure 2. Global Drug Particle Engineering Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug Particle Engineering Service Market Share by Type: 2024 VS 2031
Figure 4. Standard Drug Particle Engineering Service Features
Figure 5. Customized Drug Particle Engineering Service Features
Figure 6. Global Drug Particle Engineering Service Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Drug Particle Engineering Service Market Share by Application: 2024 VS 2031
Figure 8. Oral Medications Case Studies
Figure 9. Parenteral Medications Case Studies
Figure 10. Inhaled Medications Case Studies
Figure 11. Others Case Studies
Figure 12. Drug Particle Engineering Service Report Years Considered
Figure 13. Global Drug Particle Engineering Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Drug Particle Engineering Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Drug Particle Engineering Service Market Share by Region: 2024 VS 2031
Figure 16. Global Drug Particle Engineering Service Market Share by Players in 2024
Figure 17. Global Top Drug Particle Engineering Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Particle Engineering Service as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Drug Particle Engineering Service Revenue in 2024
Figure 19. North America Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Drug Particle Engineering Service Market Share by Country (2020-2031)
Figure 21. United States Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Drug Particle Engineering Service Market Share by Country (2020-2031)
Figure 25. Germany Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Drug Particle Engineering Service Market Share by Region (2020-2031)
Figure 33. China Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Drug Particle Engineering Service Market Share by Country (2020-2031)
Figure 41. Mexico Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Drug Particle Engineering Service Market Share by Country (2020-2031)
Figure 45. Turkey Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Drug Particle Engineering Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Lonza Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 49. CritiTech Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 50. EUROAPI Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 51. Schedio Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 52. Solid State Pharma Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 53. Hovione Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 54. Evonik Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 55. Balchem Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 56. AP-Process Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 57. Micromeritics Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 58. Wuxi AppTec Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 59. Xedev Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 60. Munit Revenue Growth Rate in Drug Particle Engineering Service Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232